New combo therapy shows promise for First-Time CLL patients
Disease control
Completed
This study tested a two-step treatment for people with chronic lymphocytic leukemia (CLL) who had not received prior therapy. First, participants received a standard chemotherapy combination (bendamustine and rituximab), followed by a year of the oral drug venetoclax. The goal wa…
Phase: PHASE2 • Sponsor: Nicole Lamanna • Aim: Disease control
Last updated May 12, 2026 13:41 UTC